ctrl K

Mirati Therapeutics Inc. (MRTX)

NASDAQ: MRTX · Real-Time Price · USD

58.70

-0.10 (-0.17%)

At close: Jan 22, 2024, 9:00 PM

Mirati Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	12.44M	72.09M	13.4M	3.33M	12.93M	n/a	n/a
Cost of Revenue	600K	508.59M	299.35M	182.87M	93.87M	58.09M	68.49M
Gross Profit	11.84M	-436.5M	-285.95M	-179.53M	-80.95M	-58.09M	-68.49M
Operating Income	-759.59M	-573.18M	-369.36M	-222.1M	-102.63M	-71.53M	-83.78M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-740.36M	-578.49M	-357.94M	-213.26M	-98.42M	-70.43M	-83.12M
Net Income	-740.87M	-581.78M	-357.43M	-212.6M	-98.42M	-70.48M	-83.14M
Selling & General & Admin	239.8M	136.68M	83.41M	42.57M	21.68M	13.45M	15.29M
Research & Development	531.63M	508.59M	299.35M	182.87M	93.87M	58.09M	68.49M
Other Expenses	19.23M	-5.3M	11.43M	8.85M	4.21M	1.1M	661K
Operating Expenses	771.42M	645.27M	382.76M	225.44M	115.55M	71.53M	83.78M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	772.02M	645.27M	382.76M	225.44M	115.55M	71.53M	83.78M
Income Tax Expense	508K	3.3M	-511K	-659K	4.21M	-130K	-155K
Shares Outstanding (Basic)	56.23M	51.88M	44.99M	37.47M	30.9M	25.29M	19.79M
Shares Outstanding (Diluted)	56.23M	51.88M	44.99M	37.47M	30.9M	25.29M	19.79M
EPS (Basic)	-13.18	-11.21	-7.94	-5.67	-3.19	-2.79	-4.2
EPS (Diluted)	-13.18	-11.21	-7.94	-5.67	-3.19	-2.79	-4.2
EBITDA	-756.66M	-571.4M	-368.72M	-222.1M	-102.63M	-71.53M	-83.78M
EBIT	-758.32M	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	2.93M	1.78M	641K	249K	175K	184K	180K